Quest Diagnostics 2025 Second Quarter Financials and Outlook

This document presents the second quarter 2025 financial results for Quest Diagnostics, a diagnostic information services provider, highlighting significant growth in revenue and earnings per share compared to the previous year. The company's press release details increased revenues of $2.76 billion and diluted EPS of $2.47 for the quarter, driven by organic growth, acquisitions, and operational efficiencies. Consequently, Quest Diagnostics has raised its full-year 2025 financial guidance, anticipating higher net revenues and adjusted diluted EPS. The report also includes detailed financial statements such as consolidated statements of operations, balance sheets, and cash flows, along with reconciliations of GAAP to non-GAAP adjusted measures, providing a comprehensive overview of their financial performance and outlook.

There are no comments yet.

Please log in to write the first comment.